MARKET

ABUS

ABUS

Arbutus Biopharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.510
-0.020
-1.31%
Closed 16:00 11/15 EST
OPEN
1.540
PREV CLOSE
1.530
HIGH
1.570
LOW
1.450
VOLUME
180.45K
TURNOVER
--
52 WEEK HIGH
5.17
52 WEEK LOW
0.8214
MARKET CAP
85.84M
P/E (TTM)
-0.5389
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ABUS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ABUS News

  • Arbutus Biopharma EPS misses by $1.26, misses on revenue
  • seekingalpha.11/06 17:32
  • Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
  • Zacks.11/06 14:35
  • Arbutus Biopharma Q3 EPS $(0.73) Misses $(0.39) Estimate, Sales $3.1M Beat $220K Estimate
  • Benzinga.11/06 14:16
  • Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update
  • GlobeNewswire.11/06 12:30

More

Industry

Pharmaceuticals
+1.25%
Pharmaceuticals & Medical Research
+1.29%

Hot Stocks

Name
Price
%Change

About ABUS

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple mechanisms of action that results in a combination therapy to cure HBV. In addition to its HBV pipeline, the Company actively licenses its Lipid Nanoparticle (LNP) technology to its industry partners. This technology represents a delivery technology in RNA interference (RNAi) therapeutic development, which has enabled several clinical trials and has been administered to hundreds of human subjects.
More

Webull offers Arbutus Biopharma Corp (ABUS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.